Üçüncü Basamak Bir Sağlık Kuruluşunda Çalışan Hekimlerde İnme Farkındalığı

Year 2021, Volume: 11 Issue: 5, 739 - 744, 17.09.2021

Erman Altunışık , Ali Zeynel Abidin Tak

https://doi.org/10.16899/jcm.970412

Abstract

Amaç: Çalışmamızın amacı 3. basamak sağlık kuruluşunda çalışan hekimlerin inme farkındalığı ve iskemik inme tedavi yaklaşımları hakkındaki bilgi birikimlerinin araştırılmasıdır. Gereç ve Yöntem: Çalışmaya yaş ortalaması 35,4 olan 59 hekim dahil edilmiştir. Çalışmada Adıyaman Üniversitesi Tıp Fakültesi eğitim araştırma hastanesinde aktif olarak görev yapan, bigilendirilmiş gönüllü onam formunu imzalayan uzman ve asistan hekimlere toplam 12 sorudan oluşan ve cevaplanması 5 dakikadan daha kısa süren anket formu ulaştırılmıştır. Bulgular: Çalışmaya katılan hekimlerin %66,1’i (n=39) uzman, %33,9’u (n=20) asistan hekim olarak görev yapmaktaydı. Katılımcıların %57,6’sı (n=34) daha önce inme ile alakalı bir bilgilendirme toplantısına katılmamıştı. Tüm sorulara verilen ortalama doğru cevap oranı %37,8 olarak ölçüldü. İnmeli hastanın ilk müdahalesi, inme prevalansı ve trombolitik tedavi ajanı ile ilgili sorulara asistan hekimlerin uzman hekimlere oranla daha yüksek oranda cevap vermiştir. İnme ile ilgili bilgilendirme toplantısına katılan hekimlerin, inmenin önlenebilirliği ve trombolitik tedavi ajanı ile ilişkili sorulara daha yüksek oranda doğru cevap vermiştir. Sonuç: İskemik inmede hastaların mortalite ve morbiditesini etkileyen en önemli faktörlerden biri kuşkusuz ki zamandır. Gerek toplumun gerekse sağlık çalışanlarının bu konuda bilinçlenmesi hayati öneme sahiptir. Tüm hekimlerin etkin eğitimler ve bilgilendirme toplantılarıyla inme ve inme tedavisi konusunda farkındalıklarının arttrılmasına ihtiyaç olduğu kanaatindeyiz.

Keywords

İskemik inme, trombolitik, farkındalık, trombektomi, hekim

Stroke Awareness of Physicians Working in a Tertiary Healthcare Institution

Abstract

Aim: To investigate the knowledge and awareness of physicians working in tertiary healthcare institutions concerning stroke and treatment approaches for ischemic stroke. Material and Method: Fifty-nine physicians with a mean age of 35.4 years were included in the study. A survey consisting of 12 questions taking less than 5 minutes to complete was delivered to the specialist and research assistant physicians who were actively employed in Adıyaman University Faculty of Medicine Training and Research Hospital and signed the voluntary informed consent form. Results: Of the physicians participating in the study, 66.1% (n=39) were working as specialists and 33.9% (n=20) as research assistant physicians. More than half the physicians (57.6%, n=34) had not previously attended an informative meeting on stroke. The average rate of correct answers given to all survey questions was 37.8%. The research assistant physicians correctly answered the questions concerning the first intervention in a stroke patient, prevalence of stroke, and thrombolytic treatment agent at a higher rate than the specialist physicians. The physicians who had previously attended an informative meeting on stroke provided more correct answers to the questions on stroke preventability and thrombolytic treatment agent. Conclusion: Undoubtedly, since time is one of the most important factors affecting mortality and morbidity in case of an ischemic stroke, it is vital that both society and healthcare professionals become aware of this health condition. We believe that the awareness of all physicians concerning stroke and its treatment should be increased through effective training and informative meetings

Keywords

Ischemic stroke, thrombolytics, awareness, thrombectomy, physician

References

• 1. Kablan Y. İnme: Epidemiyolojive Risk Faktörleri. TurkiyeKlinikleri Neurology-Special Topics. 2018;11:1-19.
• 2. Broderick JP, Phillips SJ, O'Fallon WM et al. Relationship of cardiac diseases to stroke occurrence, recurrence and mortality. Stroke 1992; 23: 1250-1256.
• 3. Powers WJ, Rabinstein AA, Ackerson T et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/ American Stroke Association. Stroke 2019; 50(12): 344-418
• 4. Harbison J, Hossain O, Jenkinson D et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003; 34(1): 71 6.
• 5. Saver JL. Time is brain--quantified. Stroke 2006; 37: 263-266.
• 6. Farrag MA, Oraby MI, Ghali AA et al. Public stroke knowledge, awareness, and response to acute stroke: Multi-center study from 4 Egyptian governorates. J Neurol Sci 2018; 384: 46-9
• 7. Park H, Jeong J, Lee H et al. Stroke awareness in Korean high school students. Acta Neurol Belg 2017; 117(2): 455-9.
• 8. Adelman EE, MeurerWJ, Nance DK et al. Stroke awareness among inpatient nursing staff at an academic medical center. Stroke 2014; 45(1): 271-3.
• 9. Yıldız D. BirinciBasamakSağlıkHizmetindeÇalışanHekimlerArasındaİskemikİnmeFarkındalığı. BakırköyTıpDergisi 2018; 14: 377-80
• 10. Davalos A, Cobo E, Molina CA et al. Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial. Lancet Neurol 2017; 16: 369-76.
• 11. Arik A, Altun Y, Tak ZA et al. INTRAVENOUS THROMBOLYTIC THERAPY IN ACUTE ISCHEMIC STROKE: EXPERIENCES OF ADIYAMAN. Turkish Journal of Cerebrovascular Diseases 2020; 26(3): 262-268
• 12. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
• 13. Nguyen-Huynh MN, Klingman JG, Avins AL et al. Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System. Stroke 2018; 49: 133-9.
• 14. Topçuoğlu MA, Arsava EM, ÖzdemirAÖ et al. Intravenous Thrombolytic Therapy in Acute Stroke: Problems and Solutions. Turk J Neurol 2017; 23: 162-175.
• 15. Emberson J, Lees KR, Lyden P et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384: 1929-35.